News from the FDA/CDC


FDA puts selinexor on fast track for DLBCL

Selinexor has received fast track designation to treat patients with previously treated DLBCL who are not eligible for certain therapies.

News from the FDA/CDC

Cigarette smoking at lowest level ever

Prevalence dropped to 14% among adults in 2017, but control strategies need to “address the diversity of tobacco products.”